What is it about?

Community-acquired pneumonia is a frequent and serious infection in older people. Guidelines often recommend adding a macrolide antibiotic (such as azithromycin or clarithromycin) to cover so-called atypical bacteria, but tetracyclines such as doxycycline can cover the same germs. In this letter we discuss whether, in older patients, there are good reasons to prefer tetracyclines, considering aspects such as side effects, drug interactions, bacterial resistance and the risk of complications like Clostridium difficile infection.

Featured Image

Why is it important?

Older patients often take many medications and are more vulnerable to antibiotic side effects. Choosing the safest option to cover atypical pathogens in pneumonia can reduce harm without losing efficacy, a practical issue for everyday hospital and community practice.

Perspectives

Short letters can raise important practical questions. This one came from daily clinical reasoning: when treating frail elderly patients, the 'standard' choice is not always the safest, and older antibiotics may deserve a second look.

Professor Stefano Di Bella
Universita degli Studi di Trieste

Read the Original

This page is a summary of: Are There Reasons To Prefer Tetracyclines to Macrolides in Older Patients with Community-Acquired Pneumonia?, Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals,
DOI: 10.1128/aac.00828-13.
You can read the full text:

Read

Contributors

The following have contributed to this page